CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH TRANSITIONS OF TOBACCO USE AMONG A COHORT OF ADULT MALE SMOKERS USING US REAL-WORLD DATA

被引:0
|
作者
Zhang, M. [1 ]
Manjelievskaia, J. [2 ]
Noggle, B. [1 ]
Cheng, H. [1 ]
Richards, M. [3 ]
Black, D. [2 ]
Smith, D. [2 ]
Edmiston, J. S. [1 ]
Rees, A. [1 ]
Gogova, M. [1 ]
机构
[1] Altria Client Serv LLC, Richmond, VA USA
[2] Merat, Cambridge, MA USA
[3] Merat, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
CO135
引用
收藏
页码:S39 / S40
页数:2
相关论文
共 50 条
  • [31] Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study
    Oka, Prawira
    Chong, Wei Ming
    Ng, Ding Xuan
    Aau, Wai Keong
    Tan, Ngiap Chuan
    FRONTIERS IN MEDICINE, 2023, 10
  • [32] Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
    Jang, Ha Young
    Kim, In-Wha
    Oh, Jung Mi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] COVID-19 in hospitalized adult patients with sickle cell disease: A 2020 US cohort using Cerner Real-World Data™ (CRWD)
    Guarino, Stephanie Howe
    Williams, Kimberly D.
    Caplan, Richard J.
    Fawcett, Mitch
    Lanzkron, Sophie
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [34] Real-World Use and Outcomes of Oral Antiplatelets Among Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
    Samuel K. Peasah
    Douglas Mager
    Kiraat D. Munshi
    Yan Huang
    Rochelle Henderson
    Elizabeth C. S. Swart
    Lynn Neilson
    Chester B. Good
    Drugs - Real World Outcomes, 2022, 9 : 121 - 127
  • [35] Real-World Use and Outcomes of Oral Antiplatelets Among Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
    Peasah, Samuel K.
    Mager, Douglas
    Munshi, Kiraat D.
    Huang, Yan
    Henderson, Rochelle
    Swart, Elizabeth C. S.
    Neilson, Lynn
    Good, Chester B.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 121 - 127
  • [36] Risk prediction modeling for cardiorenal clinical outcomes in patients with non-diabetic CKD using US nationwide real-world data
    Wanner, Christoph
    Schuchhardt, Johannes
    Bauer, Chris
    Brinker, Meike
    Kleinjung, Frank
    Vaitsiakhovich, Tatsiana
    BMC NEPHROLOGY, 2025, 26 (01)
  • [37] Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
    Heerspink, Hiddo J. L.
    Karasik, Avraham
    Thuresson, Marcus
    Melzer-Cohen, Cheli
    Chodick, Gabriel
    Khunti, Kamlesh
    Wilding, John P. H.
    Garcia Rodriguez, Luis Alberto
    Cea-Soriano, Lucia
    Kohsaka, Shun
    Nicolucci, Antonio
    Lucisano, Giuseppe
    Lin, Fang-Ju
    Wang, Chih-Yuan
    Wittbrodt, Eric
    Fenici, Peter
    Kosiborod, Mikhail
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01): : 27 - 35
  • [38] REAL-WORLD MEPOLIZUMAB USE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND SEVERE ASTHMA IMPROVES CLINICAL/ECONOMIC OUTCOMES
    Cardet, J.
    Maldonado-Puebla, M.
    Silver, J.
    Laliberte, F.
    Gao, C.
    Hilts, A.
    Hwee, J.
    Edgecomb, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S93 - S94
  • [39] Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: A chart review
    Parasuraman S.
    DiBonaventura M.
    Reith K.
    Naim A.
    Concialdi K.
    Sarlis N.J.
    Experimental Hematology & Oncology, 5 (1)
  • [40] Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
    Levy, Benjamin
    Nguyen, Danny
    Cai, Beilei
    Gorritz, Magdaliz
    Caro, Nydia
    Yasuda, Marie
    Gu, Yifan
    Chen, Chi -Chang
    Pretre, Vincent
    Saliba, Teddy
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E58 - E58